See Vaishnav, supra note 162, at 598 ("While at least one court has considered the role of patients as consumers, the more prevalent view seems to be that the patient's preferences for prescription drugs are irrelevant to the demand for such drugs") (citing In re Cardizem
CD Antitrust Litig., 105 F.
The leading case giving pay-for-delay settlements per se treatment is the Sixth Circuit's decision in In re Cardizem
CD Antitrust Litigation.
And the 6th Circuit used an even tougher standard in its 2003 decision In re Cardizem
CD Antitrust Litigation.
Christopher-Stine said she recommends starting with the calcium-channel blocker diltiazem (Cardizem
) at an average dosage of 360 mg/day (range, 120-480 mg/ day), followed by colchicine (Colcrys) 0.6 mg/day, working up to 1.8 mg/ day.
Videx EC (United Bristol Myers Squibb States and Canada) Co./Bristol Myers Squibb Canada Diltiazem Cardizem
CD 360 mg BTA Pharmaceuticals Inc.
The patient took digoxin, warfarin and cardizem
for her atrial fibrillation and glipizide and metformin for diabetes mellitus.
(160.) It is appropriate to ban a pay-for-delay settlement when the agreement appears to exceed the scope of the patent, such as in In re Cardizem
, in which the first ANDA-filer agreed not to license the 180-day period of first-mover exclusivity.
The most effective blood pressure lowering drugs--calcium channel blockers--include Cardizem
(Corona CA) received approval for a generic equivalent of the blood pressure drug Cardizem
16 March 2010 - US-based specialty pharmaceutical company Watson Pharmaceuticals Inc (NYSE: WPI) announced yesterday that its subsidiary Watson Laboratories has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem
manufactured and marketed the prescription drug Cardizem
CD, used to
Others, such as verapamil (Isoptin) and diltiazem (Cardizem
) are more likely to be used if it is necessary to lower the heart rate.
The first case, In re Cardizem
CD Antitrust Litigation, (97) involved a drug used to treat angina and hypertension and to prevent heart attacks and strokes.
She was, however, on 13 outpatient medications: Lantus, Singulair, aspirin, Niferex, Toprol, Lasix, Zestril, Lipitor, propoxyphene, Aldactone, Plavix, Prilosec, and Cardizem
, as well as home oxygen.